Clinical Trials Directory

Trials / Completed

CompletedNCT03863899

Analgesia in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation (TF-TAVI)

Pain Control With Ultrasound-guided Ilioinguinal Iliohypogastric Nerve Block Compared With Local Anesthesia Infiltration in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation (TF-TAVI): a Prospective, Randomized Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Medical University of Gdansk · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Ilioinguinal and iliohypogastric (ILIH) nerve blocks are frequently performed for analgesia in inguinal surgery. The investigators hypothesized that preoperative ultrasound-guided ilioinguinal and iliohypogastric (ILIH) nerve blocks will produce better intraoperative analgesia and less analgesic requirement postoperatively in comparison to commonly used preoperative local infiltration anaesthesia for patients undergoing transfemoral transcatheter aortic valve implantation (TF-TAVI).

Detailed description

It is a prospective, randomized trial. The patients will be randomized to one of the 2 groups: Group 1 - NERVE BLOCK. Ultrasound-guided ILIH nerve block will be performed by attending anaesthesiologist. Group 2 - LOCAL INFILTRATION. Local anaesthetic infiltration of the operative area will be performed by operator. During surgery patients will receive low-dose propofol infusion in order to achieve conscious sedation level, when indicated. An extra dose of local anaesthetic drug for infiltration of the surgical field or intravenous fentanyl or/and intravenous paracetamol will be given as rescue analgesics in patients reporting pain sensation. The patients will be observed for 24 hours. The pain at rest will be assessed using numeric rating scale (NRS 0 -10; 0 = no pain: 10 = max pain imaginable). On the first postoperative day intravenous analgesics will be given on demand (paracetamol 1 g iv (if NRS \<5) and oxycodone 2,5 mg iv (if NRS \> or = 5)).

Conditions

Interventions

TypeNameDescription
PROCEDURENerve blockdrug mixture: 10-15 ml 0.5% ropivacaine plus 5 ml 1% lidocaine plus 1 mg dexamethasone plus 50 ug adrenaline
PROCEDURELocal infiltration15-20 ml of mixture of 0.5% bupivacaine and 1% lidocaine (1:1)
PROCEDURETAVIInsertion of an aortic valve prothesis through the aorta accessed through femoral artery
DRUGAdditional intraoperative analgesiaAdministration of any analgesics during the operation
DRUGAdditional postoperative analgesiaAdministration of any analgesics within first 24 hours after the operation

Timeline

Start date
2018-07-02
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2019-03-05
Last updated
2020-01-18

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT03863899. Inclusion in this directory is not an endorsement.